Marco Colleoni
20PUBLICATIONS
244CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.Giampaolo Bianchini, Luca Malorni, Roberta Caputo
|Jan 15, 2026
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.Carmine Valenza, Yue Zheng, Monica Milano
|Jul 09, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.Fedro A Peccatori, Samuel M Niman, Ann H Partridge
|Apr 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló
|Jan 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.Stephen J Luen, Lauren C Brown, Courtney T van Geelen
|Oct 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).Nicholas Turner, Cristina Saura, Philippe Aftimos
Pageof 4
Frequent Collaborators
6 joint publications
Richard D Gelber
6 joint publications
Sherene Loi
5 joint publications
Martine Piccart
5 joint publications
Meredith M Regan
5 joint publications
Giuseppe Viale
4 joint publications
Eva Maria Ciruelos
4 joint publications
Hervé R Bonnefoi
4 joint publications
Manuel Ruíz-Borrego
3 joint publications
Fatima Cardoso
3 joint publications
Prudence A Francis
